Millennium Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-31,683
| Closed | -$48K | – | 5393 |
|
|
2023
Q1 | $48K | Sell |
31,683
-108,358
| -77% | -$164K | ﹤0.01% | 4215 |
|
|
2022
Q4 | $140K | Sell |
140,041
-128,089
| -48% | -$128K | ﹤0.01% | 4211 |
|
|
2022
Q3 | $483K | Sell |
268,130
-50,286
| -16% | -$90.6K | ﹤0.01% | 3883 |
|
|
2022
Q2 | $923K | Buy |
318,416
+218,947
| +220% | +$635K | ﹤0.01% | 3477 |
|
|
2022
Q1 | $275K | Sell |
99,469
-1,345,848
| -93% | -$3.72M | ﹤0.01% | 4487 |
|
|
2021
Q4 | $6.74M | Buy |
1,445,317
+1,156,650
| +401% | +$5.39M | ﹤0.01% | 1973 |
|
|
2021
Q3 | $2.46M | Buy |
288,667
+272,860
| +1,726% | +$2.32M | ﹤0.01% | 2846 |
|
|
2021
Q2 | $259K | Sell |
15,807
-132,536
| -89% | -$2.17M | ﹤0.01% | 4584 |
|
|
2021
Q1 | $3.28M | Sell |
148,343
-336,585
| -69% | -$7.43M | ﹤0.01% | 2447 |
|
|
2020
Q4 | $15M | Sell |
484,928
-176,173
| -27% | -$5.45M | 0.01% | 985 |
|
|
2020
Q3 | $13.4K | Buy |
661,101
+621,171
| +1,556% | +$12.6K | 0.02% | 776 |
|
|
2020
Q2 | $613K | Sell |
39,930
-31,168
| -44% | -$478K | ﹤0.01% | 2634 |
|
|
2020
Q1 | $550K | Buy |
71,098
+20,886
| +42% | +$162K | ﹤0.01% | 2259 |
|
|
2019
Q4 | $717K | Buy |
+50,212
| New | +$717K | ﹤0.01% | 2561 |
|
|
2019
Q3 | – | Sell |
-141,435
| Closed | -$2.02M | – | 3896 |
|
|
2019
Q2 | $2.02M | Sell |
141,435
-99,203
| -41% | -$1.42M | ﹤0.01% | 2013 |
|
|
2019
Q1 | $4.19M | Buy |
+240,638
| New | +$4.19M | 0.01% | 1598 |
|